The Europe single-use bioreactors market represents a critical evolution in biopharmaceutical manufacturing and bioprocessing systems.

The Europe single-use bioreactors market features a sophisticated competitive ecosystem comprising established bioprocessing technology leaders, specialized single-use system manufacturers, and ...

With several high-profile drugmakers already lining up for manufacturing space, Fujifilm Biotechnologies is on the cusp of kicking off operations at a much-anticipated mega plant in North Carolina ...

The price for Ventura's planned water recycling project has gone up by approximately $119.4 million, according to a staff report.

Capable of working with 8 individually controlled bioreactors, the BioXplorer 100 is a bioreactor system that allows for the boosting of productivity and the screening of cell culture conditions.

Protein pioneers: the countries that have approved lab-grown meat The companies working in this area have attracted significant backing from investors.

Bioreactors are relevant in the biotechnological, pharmaceutical, and industrial microbiological world because they facilitate biological reactions that are so controlled.

According to Future Market Insights, the global market for portable bioprocessing bioreactors is projected to soar to over USD 3.6 billion by 2035. That’s not incremental growth. That’s a revolution.

Conventional anaerobic biological technologies face severe challenges in removing steroid estrogens (SEs) because of the absence of electron acceptors under anaerobic conditions. In this study, an ...

Extracellular polymeric substances (EPS)-related biofouling in anaerobic electrochemical membrane bioreactors (AnEMBR) is commonly mitigated, yet the underlying mechanisms require further elucidation.